Centruroides (scorpion) immune F(ab')2 (Equine, Rare Disease Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCentruroides (scorpion) immune F(ab')2 (Equine, Rare Disease Therapeutics)
Drug Alias NameScorpion immune Fab (equine)Centruroides immune Fab (equine)Anascorp
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionScorpion venoms inhibitors
TargetsScorpion venoms
Therapy Area/IndicationsScorpion Stings
Global Approved IndicationsScorpion Stings
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2011/08/04
Country/TerritoryUnited StatesMexico
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRare Disease
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstituto Bioclon Sa De Cv
Active IndicationsScorpion Stings
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksDrugBank